TITLE

Predictive value of Sox2 expression in transurethral resection specimens in patients with T1 bladder cancer

AUTHOR(S)
Ruan, Jun; Wei, Bingbing; Xu, Zhuoqun; Yang, Shudong; Zhou, You; Yu, Minhong; Liang, Jiabei; Jin, Ke; Huang, Xing; Lu, Peng; Cheng, Huan
PUB. DATE
March 2013
SOURCE
Medical Oncology;Mar2013, Vol. 30 Issue 1, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Sox2 is thought to be an important regulator of self-renewal in embryonic stem cell. According to the cancer stem cell (CSC) theory, the overexpression of Sox2 is potentially involved in carcinogenesis and could affect tumor recurrence and metastasis. Previous study proved Sox2 might be prognostic marker for multiple human malignancies. The purpose of this study was to investigate the clinicopathological significance of Sox2 expression in human non-muscle-invasive bladder cancer. We examined Sox2 expression in 32 paired non-muscle-invasive bladder cancer tissues and adjacent non-cancerous tissues by quantitative real-time RT-PCR (qrtRT-PCR). In addition, we analyzed Sox2 and Ki-67 expression in 126 non-muscle-invasive bladder cancer samples and bladder cancer cell line T24 by immunohistochemistry and immunofluorescence assays. The recurrence-free survival was determined by Kaplan-Meier method and log-rank test. Cox regression was adopted for univariate and multivariate analyses of prognostic factors. The expression of Sox2 was significantly increased in non-muscle-invasive bladder cancer tissues. Sox2 expression was significantly correlated with that of Ki-67 ( P < 0.001). The expression of Sox2 was significantly associated with tumor size ( P = 0.006), tumor number ( P = 0.037), and tumor grade ( P < 0.001). Patients with high Sox2 expression had significantly poorer recurrence-free survival ( P = 0.0002) when compared with patients with the low expression of Sox2. On multivariate analysis, Sox2 expression and tumor grade were found to be independent prognostic factors for recurrence-free survival ( P < 0.05). Our data suggested for the first time that the high expression of Sox2 may contribute to the development of non-muscle-invasive bladder cancer and serve as a novel prognostic marker in patients with T1 bladder cancer.
ACCESSION #
85859852

 

Related Articles

  • Predicting recurrence of non-muscle-invasive bladder cancer after transurethral resection. Ðug, Haris; Jagodić, Samed; Ahmetović-Ðug, Jasmina; Selimović, Zijad; Sulejmanović, Alemdar // Medicinski Glasnik;Feb2016, Vol. 13 Issue 1, p55 

    Aim To determine clinical prognostic factors and their impact on the risk of recurrence of newly discovered non-muscle-invasive bladder cancer. Methods The study included 120 patients of both sexes aged 45- 80 years with newly discovered non-muscle-invasive bladder cancer. All the patients were...

  • SUPERFICIAL BLADDER CANCER AND OVEREXPRESSION OF p53. Lepara, Zahid; Junuzović, Dželaludin; Bajramović, Senad; Lepara, Orhan // Medical Journal;jul-sep2011, Vol. 17 Issue 3, p191 

    It is shown that recurrences of the tumor of bladder are in correlation with over expression of p53. Studies have shown that accumulation of p53 in the nucleus of tumor cells of the urinary bladder correlates with poor prognosis. The aim of this study was to examine the presence of p53 in...

  • Advantage of transurethral resection with narrow band imaging for non-muscle invasive bladder cancer. KOHEI KOBATAKE; KOJI MITA; SHINYA OHARA; MASAO KATO // Oncology Letters;Aug2015, Vol. 10 Issue 2, p1097 

    The aim of the present study was to compare the benefits of transurethral resection (TUR) under narrow band imaging (NBI-TUR) and TUR under conventional white light imaging (WLI-TUR) for non-muscle invasive bladder cancer (NMIBC). The study cohort consisted of 135 patients with NMIBC who were...

  • Ultrasound standard for obturator nerve block: the modified Taha's approach. Lin, J-A.; Nakamoto, T.; Yeh, S-D. // BJA: The British Journal of Anaesthesia;Feb2015, Vol. 114 Issue 2, p337 

    No abstract available.

  • Therapy of Superficial Bladder Carcinomas. Otto; Krege; Noll; Rübben // Urologia Internationalis;Jul99, Vol. 63 Issue 1, p32 

    Treatment of superficial bladder carcinoma was derived by several large randomized trials. This group of cancers is stratified by differentiation grade and stage in three groups of different risk profiles (Ta G1-2 vs. T1 G1-2 vs. Tis/T1 G3). Standard therapy is fractionated transurethral...

  • Second TUR often fully justified in bladder cancer. Magee, James // Urology Times;Jun2000, Vol. 28 Issue 6, p30 

    Discusses findings of a study, conducted by researchers from Munich, Germany and Graz, Austria and presented at the 15th Congress of the European Association of Urology, which showed that a second transurethral resection (TUR) in the treatment of bladder cancer provides prognostic information. ...

  • Initial bladder TUR may leave residual cancer in most patients. Scheck, Anne // Urology Times;Aug98, Vol. 26 Issue 8, p36 

    Presents information on a study which reveals that a single transurethral resection (TUR) may not be enough to successfully treat bladder cancer. First step for diagnosis and therapy of bladder cancer; Comments from Thomas-Alexander Vogeli, associate professor of urology at the University of...

  • Urological literature review: November 2007 - November 2008. Part I. Borkowski, Andrzej; Borkowski, Tomasz // Central European Journal of Urology;Mar2009, Vol. 62 Issue 1, p51 

    The article highlights several papers related to the study of urology that were published from November 2007 to November 2008. For genital traumas, one study suggested that conservative therapy may be introduced in patients with superficial traumas external to the tunica dartos. For bladder...

  • CITATIONS AND CLINICIANS' NOTES: BLADDER CANCER.  // Current Medical Literature: Urology;2004, Vol. 10 Issue 2, p53 

    Presents abstracts of articles concerning bladder cancer, published in the June 2004 issue of the periodical "Urology". Role of phosphatadylinositol-3 kinase pathway in regulating bladder cancer cell invasion; Neoadjuvant chemotherapy for transition cell carcinoma of the bladder; Randomized...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics